---
title: "Wockhardt Ltd (WOCKPHARMA) — Share Price, Financials & Analysis"
symbol: "WOCKPHARMA"
company: "Wockhardt Ltd"
canonical: "https://tapetide.com/stocks/WOCKPHARMA"
isin: "INE049B01025"
nse_symbol: "WOCKPHARMA"
bse_code: "532300"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 35431.42
generated_at: "2026-09-13T18:34:54.266Z"
---

# Wockhardt Ltd (WOCKPHARMA)

Canonical page: https://tapetide.com/stocks/WOCKPHARMA

## Company

- **NSE Symbol:** WOCKPHARMA
- **BSE Code:** 532300
- **ISIN:** INE049B01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2000-02-23
- **CEO:** Dr. Habil Fakhruddin Khorakiwala
- **Employees:** 2296
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** wockhardt.com

## About

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments). [1]

## Latest Price

- **Price:** ₹2179.4
- **Change:** -41.2 (-1.86%)
- **Open:** ₹2200
- **Day High:** ₹2237
- **Day Low:** ₹2167.3
- **Previous Close:** ₹2220.6
- **Volume:** 1109909
- **As Of:** 2026-09-11T10:27:56+00:00

## Key Fundamentals

Observed at 2026-09-11T04:43:35.789320Z.

- **Market Cap:** ₹35431.42 Cr
- **Classification:** Smallcap
- **P/E (reported):** 87.1
- **P/E (TTM):** 86.59
- **EPS (TTM):** ₹25.17
- **Book Value:** ₹304.03
- **Price to Book:** 7.3
- **Dividend Yield:** 0%
- **ROE:** 3.77%
- **ROCE:** 6.45%
- **Debt to Equity:** 0.45
- **Revenue (yearly):** ₹3484 Cr
- **Net Income:** ₹199 Cr
- **EBITDA:** ₹763 Cr
- **52-Week High:** ₹2422.3
- **52-Week Low:** ₹1086.7
- **RSI (14):** 68.87

## Tapetide Score

- **Score:** 35 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 27.49 | 9% |
| growth | 51.94 | 9% |
| momentum | 85 | 12% |
| ownership | 37.63 | 24% |
| quality | 30.29 | 22% |
| valuation | 29.91 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 7.17 times its book value
- The company has delivered a poor sales growth of 4.49% over past five years.
- Company has a low return on equity of -1.43% over last 3 years.
- Promoter holding has decreased over last 3 years: -9.31%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | 78.08% | -5.57% |
| ebitda margin growth | -23.63% | 47.97% | 417.73% | 123.93% |
| net income growth | -34.76% | -449.12% | 43% | -19% |
| revenue growth | -6.98% | 13.34% | 8% | 4% |
| roce | -29.71% | 64.96% | -372.15% | -0.36% |
| roe | -34.76% | -409.02% | -3.45% | -156.78% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 753 | 701 | 700 | 739 | 809 | 721 | 743 | 738 | 782 | 888 | 965 | 929 |
| Expenses | 681 | 664 | 759 | 648 | 699 | 593 | 679 | 666 | 604 | 711 | 740 | 737 |
| Operating Profit | 72 | 37 | -59 | 91 | 110 | 128 | 64 | 72 | 178 | 177 | 225 | 192 |
| OPM % | 10 | 5 | -8 | 12 | 14 | 18 | 9 | 10 | 23 | 20 | 23 | 21 |
| Other Income | 24 | 8 | 10 | 30 | 9 | 8 | 15 | -77 | 21 | 15 | 67 | 31 |
| Interest | 76 | 77 | 73 | 73 | 73 | 60 | 48 | 48 | 55 | 60 | 50 | 52 |
| Depreciation | 55 | 55 | 58 | 54 | 55 | 55 | 53 | 56 | 53 | 65 | 53 | 55 |
| Profit before tax | -35 | -87 | -180 | -6 | -9 | 21 | -22 | -109 | 91 | 67 | 189 | 116 |
| Tax % | 109 | -1 | -2 | 167 | 78 | 5 | 105 | -1 | 10 | 9 | 13 | 8 |
| Net Profit | -73 | -86 | -177 | -16 | -16 | 20 | -45 | -108 | 82 | 61 | 164 | 107 |
| EPS in Rs | -5.34 | -5.76 | -11.02 | -0.91 | -1.43 | 0.86 | -1.54 | -5.54 | 4.8 | 3.63 | 10.22 | 6.52 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3937 | 3566 | 2844 | 2708 | 3230 | 2651 | 2798 | 3012 | 3373 | 3564 |
| Expenses | 3935 | 3604 | 2725 | 2771 | 2932 | 2549 | 2707 | 2619 | 2721 | 2792 |
| Operating Profit | 2 | -38 | 119 | -63 | 298 | 102 | 91 | 393 | 652 | 772 |
| OPM % | 0.1 | -1.1 | 4.2 | -2.3 | 9 | 3.9 | 3.2 | 13 | 19 | 22 |
| Other Income | -238 | 116 | 133 | 975 | -163 | -173 | 17 | 62 | 26 | 134 |
| Interest | 255 | 265 | 276 | 249 | 299 | 302 | 305 | 254 | 213 | 217 |
| Depreciation | 150 | 164 | 224 | 246 | 247 | 251 | 223 | 217 | 227 | 226 |
| Profit before tax | -641 | -351 | -247 | 417 | -411 | -624 | -420 | -16 | 238 | 463 |
| Tax % | 4 | -38 | -82 | -65 | -32 | 0 | 12 | 256 | 16 | — |
| Net Profit | -667 | -217 | -43 | 688 | -279 | -621 | -472 | -57 | 199 | 414 |
| EPS in Rs | -42.3 | -13.52 | -4.81 | 47.64 | -16.94 | -38.8 | -30.18 | -2.89 | 13.11 | 25.17 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 55 | 55 | 55 | 55 | 55 | 72 | 72 | 77 | 81 | 81 |
| Reserves | 3281 | 2797 | 2619 | 2616 | 3321 | 3777 | 3282 | 3282 | 4272 | 4859 |
| Borrowings | 4160 | 3748 | 3375 | 3582 | 2674 | 2198 | 2184 | 2356 | 2021 | 2233 |
| Other Liabilities | 1486 | 1528 | 1764 | 1894 | 1696 | 2168 | 2113 | 1899 | 1726 | 1405 |
| Total Liabilities | 8982 | 8128 | 7813 | 8148 | 7746 | 8215 | 7651 | 7614 | 8100 | 8578 |
| Fixed Assets | 2773 | 2888 | 3058 | 3502 | 3343 | 3462 | 3042 | 2881 | 2736 | 2791 |
| CWIP | 1244 | 1433 | 1445 | 1585 | 1379 | 1342 | 1539 | 1722 | 2033 | 2379 |
| Investments | 563 | 214 | 0 | 0 | 0 | 0 | 0 | 0 | 422 | 412 |
| Other Assets | 4403 | 3593 | 3309 | 3060 | 3024 | 3411 | 3070 | 3011 | 2909 | 2996 |
| Total Assets | 8982 | 8128 | 7813 | 8148 | 7746 | 8215 | 7651 | 7614 | 8100 | 8578 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -269 | 68 | 183 | 649 | -287 | 413 | 153 | 219 | -22 | 390 |
| Cash from Investing Activity | -684 | 635 | 93 | -147 | 1471 | -204 | -118 | -138 | -780 | -231 |
| Cash from Financing Activity | 1254 | -769 | -776 | -680 | -1171 | -71 | -315 | 334 | 409 | -54 |
| Net Cash Flow | 301 | -66 | -500 | -178 | 13 | 138 | -280 | 415 | -393 | 105 |
| Free Cash Flow | -678 | -238 | 127 | 486 | -452 | 202 | 23 | 69 | -377 | 76 |
| CFO/OP | -1887 | 4697 | -583 | 560 | 270 | 171 | 161 | 274 | -13 | 63 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 94 | 89 | 130 | 159 | 124 | 104 | 110 | 81 | 80 | 64 |
| Inventory Days | 243 | 174 | 183 | 209 | 256 | 222 | 216 | 201 | 234 | 286 |
| Days Payable | 117 | 122 | 187 | 272 | 223 | 265 | 285 | 240 | 191 | 182 |
| Cash Conversion Cycle | 220 | 141 | 126 | 97 | 157 | 60 | 41 | 41 | 123 | 168 |
| Working Capital Days | 36 | -56 | -51 | -171 | -133 | -116 | -186 | -163 | -23 | 35 |
| ROCE % | -1 | -1 | -1 | -1 | -3 | 1 | 0 | -1 | 4 | 8 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 55.14% | 54.93% | 51.6% | 51.99% | 51.99% | 49.09% | 49.09% | 49.09% | 49.08% | 49.08% | 49.08% | 49.08% |
| FIIs | 3.02% | 4.18% | 5.49% | 5.93% | 6.7% | 6.54% | 6.81% | 7.29% | 7.1% | 6.99% | 7.09% | 7.22% |
| DIIs | 0.22% | 0.1% | 4.83% | 4.45% | 5.09% | 9.82% | 10.59% | 11.01% | 11.01% | 10.55% | 10.96% | 9.24% |
| Government | 0% | 0% | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.04% | 0.02% |
| Public | 32.89% | 32.94% | 29.94% | 30.18% | 29.02% | 27.49% | 26.69% | 26.05% | 26.1% | 26.52% | 25.89% | 27.31% |
| Others | 8.72% | 7.85% | 8.13% | 7.43% | 7.19% | 7.04% | 6.8% | 6.55% | 6.69% | 6.84% | 6.94% | 7.13% |
| No. of Shareholders | 172989 | 161813 | 146376 | 140391 | 138142 | 142710 | 141799 | 146918 | 137946 | 142274 | 139016 | 166518 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 6 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2075.87 | Buy |
| EMA (10) | 2113.65 | Buy |
| SMA (20) | 1984.11 | Buy |
| EMA (20) | 2039.13 | Buy |
| SMA (50) | 1935.93 | Buy |
| EMA (50) | 1951.78 | Buy |
| SMA (100) | 1848.43 | Buy |
| EMA (100) | 1840.37 | Buy |
| SMA (200) | 1598.61 | Buy |
| EMA (200) | 1701.89 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.36 | Neutral |
| MACD (12,26,9) | 78.63 | Buy |
| Stochastic (14,3,3) | 87.13 | Sell |
| ADX (14) | 22.3 | Neutral |
| Williams %R (14) | -21.27 | Neutral |
| ATR (14) | 80.38 | High Volatility |
| ROC (12) | 15.8 | Buy |
| Stoch RSI (14) | 72.1 | Neutral |
| UO (7,14,28) | 62.45 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efc3f577-a8da-4812-af42-4e97cb1fe889.pdf) |
| 2026-08-25 | [Disclosure under Regulation 30A of LODR](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4e7063d-a87b-429d-9420-944df5c2e0d7.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b05bad9-2301-4039-8da0-ae77e0a4e9ac.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb82a5e-3ee8-4175-bf5a-0a711b1c0585.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0ef7ac3-0940-4c0e-82e3-cead6427d2b8.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bba33d1-85fc-48d0-811f-db703758cfd4.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a31661c9-2c3c-49c8-b0e0-78cc3220c8fa.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=512035ac-dfb1-4e72-935d-2925ca0b683f.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f46e7a6d-3825-4a76-99fe-a3d430f97ac7.pdf) |
| 2026-08-05 | [Addendum To The Notice Of 27Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17ee73bd-82fe-49e8-abc1-72a835739e1c.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bdab4be-efc7-4856-91da-850d3b7b5888.pdf) |
| 2026-05-04 | [Outcome Of The Board Meeting Held On 4Th May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40966ee3-c638-4125-856f-d0e02459b9f8.pdf) |
| 2026-02-10 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df5a90e4-ae67-435e-ab91-11731ab9fef9.pdf) |
| 2025-11-03 | [Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9b0108-a562-499f-92cb-978f4f7e64b9.pdf) |
| 2025-08-08 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6c10897-e8de-49ea-8ffc-ae919060aa5f.pdf) |
| 2025-05-29 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bd6f3ea-cd91-4926-a06c-63d617ab3dd7.pdf) |
| 2025-05-29 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a54ea2-502e-4b33-b9f1-cc1d8807cf98.pdf) |
| 2024-11-13 | [Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d8d0fa0-04b7-44a3-8a31-e3b76de5b3b1.pdf) |
| 2024-08-09 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3cf4371-c2eb-4aef-aa66-fe01c309da8a.pdf) |
| 2024-05-28 | [Outcome Of The Board Meeting Held On May 28, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12bd8d99-7b9e-4c6f-9abb-47f54b181090.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-06-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3f55a26-72c3-43d4-90c1-f2384c4568b9.pdf) |
| 2025-06-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c50e942-c9ad-4a5a-840f-10e4b31f502c.pdf) |
| 2023-02-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e98d36a0-d558-468c-af67-b444a5f94842.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-06-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0e57421-889a-4489-84f3-57db3e475834.pdf) |
| 2025-06-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e0435e0-06b2-41bc-8a9a-70ec2534cf18.pdf) |
| 2025-06-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=163c4bb3-3eeb-4f48-857d-3931854e5e37.pdf) |
| 2024-10-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4621e1ef-09ad-4f6c-aff3-b3eff866e4e1.pdf) |
| 2024-02-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3413422b-6fcb-4520-88bf-8a86a7fc9de3.pdf) |
| 2022-03-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c17371e-4307-4abb-88e5-6d610dceb010.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4621e1ef-09ad-4f6c-aff3-b3eff866e4e1.pdf) |
| Mar 2022 | [Concall - Mar 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c17371e-4307-4abb-88e5-6d610dceb010.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f0e57421-889a-4489-84f3-57db3e475834.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/163c4bb3-3eeb-4f48-857d-3931854e5e37.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c50e942-c9ad-4a5a-840f-10e4b31f502c.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2ffa58a-68a0-4191-a436-71c4e59e4fc7.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e2ffa58a-68a0-4191-a436-71c4e59e4fc7.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3413422b-6fcb-4520-88bf-8a86a7fc9de3.pdf) |
| Feb 2023 | [Concall - Feb 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e98d36a0-d558-468c-af67-b444a5f94842.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Certificate As per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate As per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5018700-48df-44d7-82ed-c2d3ac35feb6.pdf) |
| 4 May - Wockhardt reports QIP proceeds monitoring for quarter ended March 31, 2026; no deviation, utilization extended to FY2028. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 4 May - Wockhardt reports QIP proceeds monitoring for quarter ended March 31, 2026; no deviation, utilization extended to FY2028.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ba143799-3472-4c13-a4e5-0941c0f5714c.pdf) |
| 4 May - Wockhardt reported FY26 PBT of Rs.238 crore, revenue of Rs.3,373 crore, and Q4 FY26 PBT of Rs.189 crore. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 4 May - Wockhardt reported FY26 PBT of Rs.238 crore, revenue of Rs.3,373 crore, and Q4 FY26 PBT of Rs.189 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/29135ac7-3652-4b17-b2f6-7319aa5da52c.pdf) |
| 4 May - Wockhardt designated Annapurna Das, Om Narayan and Sunil Soni as SMPs on 4 May 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 4 May - Wockhardt designated Annapurna Das, Om Narayan and Sunil Soni as SMPs on 4 May 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e27ba1be-41ac-4c46-a449-7e316e09ba68.pdf) |
| 4 May - Board approved FY26 audited results; standalone profit Rs317 crore, consolidated profit Rs199 crore, and proposed fund raise. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th May, 2026 4 May - Board approved FY26 audited results; standalone profit Rs317 crore, consolidated profit Rs199 crore, and proposed fund raise.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cc232a3e-a2a2-42ab-a4e4-9f28d886fe19.pdf) |
| 30 Mar - CDSCO SEC favours marketing approval for Zaynich (zidebactam/cefepime) for Gram-negative infections (30 Mar 2026). | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Mar - CDSCO SEC favours marketing approval for Zaynich (zidebactam/cefepime) for Gram-negative infections (30 Mar 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5ba0d6e-7658-4d1f-a678-543332b8d4be.pdf) |
| 25 Mar - Trading window closed from 1 April 2026 until 48 hours after FY2026 audited results declaration. | [Closure of Trading Window 25 Mar - Trading window closed from 1 April 2026 until 48 hours after FY2026 audited results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02a0bc2e-31ca-43d6-badc-759a421a44d6.pdf) |
| 20 Feb - Read with Schedule III Part A Para A of SEBI (LODR) Regulations, 2015, we enclose herewith a copy of the newspaper advertisement published today i.e … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Feb - Read with Schedule III Part A Para A of SEBI (LODR) Regulations, 2015, we enclose herewith a copy of the newspaper advertisement published today i.e …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2775d87d-5368-464c-892b-62dcdec4f145.pdf) |
| 1d - Board meets 4 May 2026 to approve FY26 audited results and consider fund raising. | [Board Meeting Intimation for Intimation Of The Meeting Of Board Of Wockhardt Limited ('The Company') 1d - Board meets 4 May 2026 to approve FY26 audited results and consider fund raising.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/004dd88b-aabf-4828-a4ef-fbdbbae0d27a.pdf) |
| 19 Feb - NSE Sustainability assigned ESG score 65 for 2025 (E51, S70, G74); independently determined. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - ESG Ratings. 19 Feb - NSE Sustainability assigned ESG score 65 for 2025 (E51, S70, G74); independently determined.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61ebdb6e-7bd3-4d8e-a8d7-7d4c1b0a5291.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_WOCKPHARMA_2010_2011_16092011055556.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3beb80a8-cec1-4973-b9f4-1d4be7cb11d0.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae30b5ab-b461-46aa-ae0b-2ffd25da4f56.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ffc139d3-7b82-4c15-8f90-be0d24e0a6d6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1cf5ead8-f002-4829-bca1-ff612b3e0b1d.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532300/73832532300.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532300/68849532300.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532300/5323000320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532300/5323000319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532300/5323000318.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2023-02-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505a86d4-d851-4739-b561-c9c1018cedc0.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:34:54.266Z.